Faa'iidooyinka & Caymiska
Dukaamaysiga & Barashada
How to Read Your Explanation of Health Care Benefits (EOB) Statement
Natiijooyinka Raadinta
Soo bandhiga 2681 - 2690 ee natiijooyinka 4229
Bixiye
P19R2-18 Update: New Remittance Code OA-45/N801 for Purchased/Referred Care (PRC) - Eligible Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Bixiye
P26-17 New Drug-Related Prior Authorization (PA) Criteria: Urea Cycle Disorders
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Bixiye
P54-16 Added Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2016
Bixiye
P18-17 New Drug-Related Prior Authorization Requirements for Nusinersen (Spinraza)
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2017
Bixiye
P59-18 New Acupuncture Update for Commercial Lines of Business - Effective January 1, 2019
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2018
Bixiye
P59-17 Government Programs Subscribers Prior Authorization Requirement for Spinal Fusion: Lumbar
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2017
Bixiye
P53-17 New Drug-Related Prior Authorization Requirements for Edaravone (Radicava) and Cerliponase Alfa (Brineura)
Taariikhda uu dhaqangalayo barnaamijka: Okt 10, 2017
Bixiye
P58-16 Changes to Prior Authorization for Infertility for Commercial Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: Nov 28, 2016
Bixiye
P6-18 Addition of Drug to the Self-Administered Oncology PA with QL Program
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2018